DR. HARRY LOUIS LEIDER, M.D.
Osteopathic Medicine at Lombard St, Baltimore, MD
License number
Maryland D0062311
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
300 E Lombard St SUITE 1610, Baltimore, MD 21202
Phone
(443) 769-1613
(443) 220-0122 (Fax)
(443) 220-0122 (Fax)
Personal information
See more information about HARRY LOUIS LEIDER at radaris.comName
Address
Phone
11805 Centurion Way, Potomac, MD 20854
1685 Bullock Cir, Owings Mills, MD 21117
1685, Owings Mills, MD 21117
Professional information
Chief Medical Officer &Amp; Senior Vice Presideent At Ameritox
Position:
Chief Medical Officer & Senior Vice President at Ameritox
Location:
Baltimore, Maryland Area
Industry:
Medical Devices
Work:
Ameritox
since Sep 2008
-
Chief Medical Officer & Senior Vice President
XLHealth
Apr 2005 - Sep 2008
-
Senior Vice President and Chief Medical Officer
Interactive Forums - IFI Health Solutions
Jan 2001 - Apr 2005
-
President of IFI Health Solutions
Education:
University of Washington, Michael G. Foster School of Business 1987 - 1989
MBA, Management University of Pennsylvania School of Medicine 1979 - 1983
MD, MedicineMBA, University of Washington, 1989
MBA, Management University of Pennsylvania School of Medicine 1979 - 1983
MD, MedicineMBA, University of Washington, 1989
Interests:
Running, travel, wine
Honor & Awards:
Robert Wood Johnson Clinical Scholar 1987-1989, Chief Resident, Graduate Hospital of the University of Pennsylvania, 1986-87, Class President, University of Pennsylvania School of Medicine, Ralph Dorn Hetzel Award, for leadership, scholarship, and community service, Pennsylvania State University, 1979
Harry Louis Leider, Baltimore MD
Specialties:
Internist
Address:
300 E Lombard St, Baltimore, MD 21202
Education:
University of Pennsylvania, Perelman School of Medicine - Doctor of Medicine
Hospital of the University of Pennsylvania - Residency - Internal Medicine
Hospital of the University of Pennsylvania - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine
Dr. Harry L Leider, Baltimore MD - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
300 E Lombard St SUITE 1610, Baltimore 21202
(443) 220-0122 (Fax)
(443) 220-0122 (Fax)
Certifications:
Internal Medicine, 1986
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Perelman School of Medicine University of Pennsylvania
Graduated: 1983
Graduate Hospital
Rw Johnson Clin Scholars Pr
Perelman School of Medicine University of Pennsylvania
Graduated: 1983
Graduate Hospital
Rw Johnson Clin Scholars Pr
Chief Medical Officer/Svp At Ameritox
Location:
Baltimore, Maryland Area
Industry:
Health, Wellness and Fitness
Harry Leider
Location:
Baltimore, Maryland Area
Industry:
Hospital & Health Care
Methods Of Normalizing Measured Drug Concentrations And Testing For Non-Compliance With A Drug Treatment Regimen
US Patent:
2011019, Aug 11, 2011
Filed:
Feb 11, 2010
Appl. No.:
12/704169
Inventors:
Harry Leider - Baltimore MD, US
Ariel Linden - Baltimore MD, US
Ariel Linden - Baltimore MD, US
Assignee:
AMERITOX, LTD. - Baltimore MD
International Classification:
G01N 33/53
US Classification:
436501
Abstract:
Methods for monitoring subject compliance with a prescribed treatment regimen are disclosed. In one embodiment, the method comprises measuring a drug level in fluid of a subject and normalizing said measured drug level as a function of one or more parameters associated with the subject. The normalized drug level is compared to a reference value and associated confidence intervals or to a concentration range. The reference value and associated confidence intervals and/or the concentration range may be normalized based on one or more parameters associated with subjects in a reference population.
Methods Of Normalizing Measured Drug Concentrations And Testing For Non-Compliance With A Drug Treatment Regimen
US Patent:
2011019, Aug 11, 2011
Filed:
Feb 11, 2010
Appl. No.:
12/704186
Inventors:
Harry Leider - Baltimore MD, US
Ariel Linden - Baltimore MD, US
Ariel Linden - Baltimore MD, US
Assignee:
Ameritox, Ltd. - Baltimore MD
International Classification:
G01N 33/53
US Classification:
436501
Abstract:
Methods for monitoring subject compliance with a prescribed treatment regimen are disclosed. In one embodiment, the method comprises measuring a drug level in fluid of a subject and normalizing said measured drug level as a function of one or more parameters associated with the subject. The normalized drug level is compared to a reference value and associated confidence intervals or to a concentration range. The reference value and associated confidence intervals and/or the concentration range may be normalized based on one or more parameters associated with subjects in a reference population.
Methods Of Normalizing Measured Drug Concentrations And Testing For Non-Compliance With A Drug Treatment Regimen
US Patent:
2011022, Sep 15, 2011
Filed:
Feb 11, 2011
Appl. No.:
13/025400
Inventors:
Harry Leider - Baltimore MD, US
Ariel Linden - Baltimore MD, US
Ariel Linden - Baltimore MD, US
Assignee:
AMERITOX, LTD. - Baltimore MD
International Classification:
G06F 17/18, H01J 49/26
US Classification:
702 19
Abstract:
Methods for monitoring subject compliance with a prescribed treatment regimen are disclosed. In one embodiment, the method comprises measuring a drug level in fluid of a subject and normalizing said measured drug level as a function of one or more parameters associated with the subject. The normalized drug level is compared to a reference value and associated confidence intervals or to a concentration range. The reference value and associated confidence intervals and/or the concentration range may be normalized based on one or more parameters associated with subjects in a reference population.